X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3013) 3013
Book Review (338) 338
Publication (66) 66
Magazine Article (16) 16
Conference Proceeding (8) 8
Newsletter (7) 7
Newspaper Article (3) 3
Dissertation (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2567) 2567
index medicus (2555) 2555
hypertension - drug therapy (1817) 1817
male (1786) 1786
female (1724) 1724
middle aged (1633) 1633
hydrochlorothiazide - therapeutic use (1276) 1276
aged (1269) 1269
hydrochlorothiazide (1256) 1256
hydrochlorothiazide - adverse effects (1251) 1251
hypertension (1040) 1040
adult (1032) 1032
blood pressure - drug effects (965) 965
drug therapy, combination (950) 950
antihypertensive agents - therapeutic use (789) 789
hydrochlorothiazide - administration & dosage (710) 710
antihypertensive agents - adverse effects (641) 641
double-blind method (638) 638
diuretics (579) 579
pharmacology & pharmacy (531) 531
hypertension - physiopathology (526) 526
treatment outcome (481) 481
abridged index medicus (478) 478
antihypertensive agents - administration & dosage (439) 439
peripheral vascular disease (423) 423
drug combinations (418) 418
blood-pressure (381) 381
blood pressure (331) 331
clinical trials as topic (310) 310
diuretics - therapeutic use (305) 305
drug therapy (302) 302
diuretics - adverse effects (279) 279
medicine, general & internal (278) 278
time factors (242) 242
tetrazoles - therapeutic use (241) 241
amlodipine (231) 231
dose-response relationship, drug (231) 231
aged, 80 and over (227) 227
risk factors (227) 227
therapy (217) 217
valsartan (215) 215
cardiac & cardiovascular systems (212) 212
hydrochlorothiazide - pharmacology (210) 210
prospective studies (210) 210
double-blind (209) 209
tetrazoles - adverse effects (209) 209
hypertension - complications (208) 208
combination therapy (198) 198
efficacy (190) 190
potassium - blood (186) 186
risk (185) 185
adolescent (184) 184
heart rate - drug effects (183) 183
angiotensin-converting enzyme inhibitors - therapeutic use (181) 181
hypertension - blood (180) 180
medicine & public health (178) 178
internal medicine (172) 172
losartan (172) 172
dosage and administration (169) 169
tetrazoles - administration & dosage (169) 169
angiotensin ii type 1 receptor blockers - therapeutic use (162) 162
random allocation (158) 158
management (157) 157
sodium chloride symporter inhibitors - therapeutic use (154) 154
mortality (150) 150
prevention (149) 149
sodium chloride symporter inhibitors - adverse effects (146) 146
calcium channel blockers - therapeutic use (144) 144
amlodipine - therapeutic use (143) 143
diuretics - administration & dosage (141) 141
research (141) 141
antihypertensive agents - pharmacology (140) 140
antihypertensive drugs (131) 131
animals (129) 129
angiotensin-converting enzyme inhibitors - adverse effects (125) 125
combination (125) 125
follow-up studies (124) 124
valine - analogs & derivatives (121) 121
care and treatment (120) 120
enalapril (120) 120
health aspects (120) 120
pharmacology/toxicology (119) 119
angiotensin ii type 1 receptor blockers - adverse effects (118) 118
hypokalemia - chemically induced (118) 118
trial (116) 116
amlodipine - adverse effects (115) 115
benzimidazoles - therapeutic use (112) 112
enalapril - therapeutic use (112) 112
amlodipine - administration & dosage (111) 111
tolerability (110) 110
angiotensin-converting enzyme inhibitors - administration & dosage (108) 108
antihypertensive therapy (104) 104
drugs (103) 103
safety (102) 102
amiloride - adverse effects (101) 101
medicine, research & experimental (101) 101
urology & nephrology (99) 99
analysis (98) 98
imidazoles - therapeutic use (97) 97
losartan - therapeutic use (96) 96
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2755) 2755
German (94) 94
Russian (37) 37
Spanish (37) 37
French (30) 30
Italian (25) 25
Japanese (8) 8
Norwegian (8) 8
Polish (7) 7
Chinese (6) 6
Czech (6) 6
Danish (6) 6
Portuguese (6) 6
Dutch (3) 3
Swedish (3) 3
Finnish (2) 2
Hebrew (2) 2
Hungarian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Korean (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9721, pp. 1173 - 1181
Summary Background The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that... 
Internal Medicine | KIDNEY-DISEASE | AMLODIPINE | BENAZEPRIL | MEDICINE, GENERAL & INTERNAL | CONVERTING-ENZYME-INHIBITOR | ALBUMINURIA | NITRIC-OXIDE | INSUFFICIENCY | DIABETIC-NEPHROPATHY | BLOOD-PRESSURE | PROGRESSION | Blood Pressure | Calcium Channel Blockers - adverse effects | Benzazepines - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Kidney Failure, Chronic - urine | Male | Albuminuria | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Amlodipine - administration & dosage | Hydrochlorothiazide - adverse effects | Kidney Failure, Chronic - physiopathology | Diuretics - administration & dosage | Glomerular Filtration Rate | Double-Blind Method | Risk Factors | Amlodipine - adverse effects | Hydrochlorothiazide - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Disease Progression | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Calcium Channel Blockers - administration & dosage | Kidney Failure, Chronic - complications | Creatinine - blood | Hypertension - complications | Aged | Benzazepines - administration & dosage | Diuretics - adverse effects | Drug Combinations | Hypertension | Chronic kidney failure | Patient outcomes | Development and progression | Drug therapy, Combination | Drug therapy | Methods | Risk factors | Studies | Heart failure | Blister packs | Mortality | Kidney diseases | Diabetes | Index Medicus | Abridged Index Medicus | Drugs | blood pressure | Side effects | Filtration | secondary analysis | Dialysis | clinical trials | hypertension | Kidney
Journal Article
Journal of Hypertension, ISSN 0263-6352, 05/2003, Volume 21, Issue 5, pp. 875 - 886
BACKGROUNDThe prognostic benefits of blood pressure lowering treatment in elderly hypertensive patients were established more than a decade ago, but are less... 
Hypertension | Cardiovascular events | Angiotensin II type 1-receptor blockade | Cognitive function | Candesartan | Elderly | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Antihypertensive Agents - administration & dosage | Dementia - diagnosis | Dementia - physiopathology | Hypertension - drug therapy | Male | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Time Factors | Tetrazoles - administration & dosage | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Hypertension - mortality | Benzimidazoles - adverse effects | Hypertension - diagnosis | Benzimidazoles - therapeutic use | Cardiovascular Diseases - diagnosis | Hydrochlorothiazide - adverse effects | Severity of Illness Index | Cardiovascular Diseases - physiopathology | Double-Blind Method | Risk Reduction Behavior | Europe - epidemiology | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Biomarkers - blood | Antihypertensive Agents - therapeutic use | Cognition - drug effects | Antihypertensive Agents - adverse effects | Survival Analysis | Helsinki Declaration | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Hydrochlorothiazide - therapeutic use | Index Medicus | Comparative Study | Cardiovascular Diseases/diagnosis/mortality/physiopathology | Dose-Response Relationship; Drug | Biological Markers/blood | Europe/epidemiology | Aged; 80 and over | Research Support; Non-U.S. Gov't | Antihypertensive Agents/administration & dosage/adverse effects/therapeutic use | Benzimidazoles/administration & dosage/adverse effects/therapeutic use | Hydrochlorothiazide/administration & dosage/adverse effects/therapeutic use | Tetrazoles/administration & dosage/adverse effects/therapeutic use | Dementia/diagnosis/physiopathology | Blood Pressure/drug effects | Cognition/drug effects | Hypertension/diagnosis/drug therapy/mortality
Journal Article
Hypertension, ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 276 - 284
Thiazide diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers all cause reactive rises in plasma renin activity. We... 
Hypertension | Aliskiren | Renin inhibitor | Renin-angiotensin-aldosterone system | Combination therapy | Plasma renin activity | Ambulatory blood pressure measurement | plasma renin activity | DESIGN | ANTAGONIST | MYOCARDIAL-INFARCTION | EFFICACY | aliskiren | RISK FACTOR | ambulatory blood pressure measurement | SOCIETY | ALDOSTERONE SYSTEM | renin-angiotensin-aldosterone system | CARDIOVASCULAR-DISEASE | combination therapy | PERIPHERAL VASCULAR DISEASE | renin inhibitor | ESSENTIAL-HYPERTENSION | hypertension | INTERRUPTION | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Amides | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Biphenyl Compounds - therapeutic use | Hypertension - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Drug Therapy, Combination | Hypertension - diagnosis | Ramipril - adverse effects | Hydrochlorothiazide - adverse effects | Fumarates - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Fumarates - blood | Renin - antagonists & inhibitors | Tetrazoles - therapeutic use | Aged | Patient Compliance | Tetrazoles - adverse effects | Blood Pressure Monitoring, Ambulatory | Hydrochlorothiazide - therapeutic use | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 23, pp. 2417 - 2428
Journal Article
Kidney International, ISSN 0085-2538, 06/2008, Volume 73, Issue 11, pp. 1303 - 1309
Clinical practice guidelines recommend blockers of the renin-angiotensin system alone or in combination with other agents to reduce blood pressure and... 
albuminuria | diabetes mellitus | benazepril | hypertension | amlodipine | hydrochlorothiazide | Hypertension | Amlodipine | Benazepril | Albuminuria | Hydrochlorothiazide | Diabetes mellitus | RENAL-FUNCTION | RISK | DIABETIC-NEPHROPATHY | BLOOD-PRESSURE | GLOMERULAR-FILTRATION-RATE | MICROALBUMINURIA | DISEASE | UROLOGY & NEPHROLOGY | ESSENTIAL-HYPERTENSION | PROGRESSION | Calcium Channel Blockers - adverse effects | Diabetic Nephropathies - etiology | Benzazepines - adverse effects | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Diabetic Nephropathies - drug therapy | Hypertension - drug therapy | Male | Hypertension - etiology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Blood Pressure - drug effects | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hydrochlorothiazide - adverse effects | Albuminuria - etiology | Double-Blind Method | Amlodipine - adverse effects | Treatment Outcome | Benzazepines - pharmacology | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Benzazepines - therapeutic use | Albuminuria - drug therapy | Diuretics - therapeutic use | Aged | Hydrochlorothiazide - therapeutic use | Diuretics - adverse effects | Index Medicus
Journal Article
The Lancet, ISSN 0140-6736, 06/2004, Volume 363, Issue 9426, pp. 2022 - 2031
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial was designed to test the hypothesis that for the same blood-pressure control, valsartan... 
CALCIUM-CHANNEL BLOCKER | LIPID-LOWERING TREATMENT | RECEPTOR BLOCKER | MEDICINE, GENERAL & INTERNAL | ISOLATED SYSTOLIC HYPERTENSION | CONVERTING-ENZYME-INHIBITOR | DOUBLE-BLIND | ANGIOTENSIN-II | ELECTROCARDIOGRAPHIC IDENTIFICATION | CORONARY-ARTERY-DISEASE | BLOOD-PRESSURE | Calcium Channel Blockers - adverse effects | Valsartan | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - therapeutic use | Angiotensin II Type 1 Receptor Blockers | Endpoint Determination | Diuretics | Female | Blood Pressure - drug effects | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Amlodipine - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Tetrazoles - adverse effects | Valine - adverse effects | Hydrochlorothiazide - therapeutic use | Hypertension | Medical research | Side effects | Drug therapy | Drugs | Heart attacks | Heart surgery | Angioplasty | Risk | Cardiovascular disease | Blood | Randomization | Measurement techniques | Blood pressure | Heart diseases | Age | Heart failure | Edema | Stroke | Mortality | Medical treatment | Health risks | Angina pectoris | Patients | Coronary artery disease | Morbidity | Hypotheses | Coronary vessels | Diabetes | Cardiovascular diseases | Health risk assessment | Mercury | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article